FDA Inspection
Nexus Pharmaceuticals, LLCNexus Pharmaceuticals, LLC – FDA Inspection, Nov 5, 2014
Record Details
This FDA Inspection record concerns Nexus Pharmaceuticals, LLC, with an inspection on November 5, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nexus Pharmaceuticals, LLC
- Inspection Date
- November 5, 2014
- Product Type
- Drugs
View Company Profile
ID · 32cc3842-5652-47d9-ae6e-69f963728a59
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 903661
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nexus Pharmaceuticals, LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | VAI | Chicago District Office | Drug Quality Assurance |
| November 7, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 25, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nexus Pharmaceuticals, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.